219 related articles for article (PubMed ID: 23162074)
1. Metastatic biomarker discovery through proteomics.
Brinton LT; Brentnall TA; Smith JA; Kelly KA
Cancer Genomics Proteomics; 2012 Nov; 9(6):345-55. PubMed ID: 23162074
[TBL] [Abstract][Full Text] [Related]
2. Mining the Human Proteome: Biomarker Discovery for Human Cancer and Metastases.
Yang J; Roy R; Jedinak A; Moses MA
Cancer J; 2015; 21(4):327-36. PubMed ID: 26222086
[TBL] [Abstract][Full Text] [Related]
3. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
4. Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.
Hudler P; Kocevar N; Komel R
ScientificWorldJournal; 2014; 2014():260348. PubMed ID: 24550697
[TBL] [Abstract][Full Text] [Related]
5. Oncoproteomics: Trials and tribulations.
Zhou L; Li Q; Wang J; Huang C; Nice EC
Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
[TBL] [Abstract][Full Text] [Related]
6. Contribution of oncoproteomics to cancer biomarker discovery.
Cho WC
Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
[TBL] [Abstract][Full Text] [Related]
7. Proteomic profiling of human plasma for cancer biomarker discovery.
Huang Z; Ma L; Huang C; Li Q; Nice EC
Proteomics; 2017 Mar; 17(6):. PubMed ID: 27550791
[TBL] [Abstract][Full Text] [Related]
8. Towards defining biomarkers indicating resistances to targeted therapies.
Stehle F; Schulz K; Seliger B
Biochim Biophys Acta; 2014 May; 1844(5):909-16. PubMed ID: 24269379
[TBL] [Abstract][Full Text] [Related]
9. The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients.
Kelleher MT; Fruhwirth G; Patel G; Ofo E; Festy F; Barber PR; Ameer-Beg SM; Vojnovic B; Gillett C; Coolen A; Kéri G; Ellis PA; Ng T
Target Oncol; 2009 Sep; 4(3):235-52. PubMed ID: 19756916
[TBL] [Abstract][Full Text] [Related]
10. Tumor biomarkers for diagnosis, prognosis and targeted therapy.
Zhou Y; Tao L; Qiu J; Xu J; Yang X; Zhang Y; Tian X; Guan X; Cen X; Zhao Y
Signal Transduct Target Ther; 2024 May; 9(1):132. PubMed ID: 38763973
[TBL] [Abstract][Full Text] [Related]
11. Plasma membrane proteomics and its application in clinical cancer biomarker discovery.
Leth-Larsen R; Lund RR; Ditzel HJ
Mol Cell Proteomics; 2010 Jul; 9(7):1369-82. PubMed ID: 20382631
[TBL] [Abstract][Full Text] [Related]
12. Biomarker discovery of nasopharyngeal carcinoma by proteomics.
Xiao L; Xiao T; Wang ZM; Cho WC; Xiao ZQ
Expert Rev Proteomics; 2014 Apr; 11(2):215-25. PubMed ID: 24611579
[TBL] [Abstract][Full Text] [Related]
13. Recent findings from the Human Proteome Project: opening the mass spectrometry toolbox to advance cancer diagnosis, surveillance and treatment.
Cantor DI; Nice EC; Baker MS
Expert Rev Proteomics; 2015 Jun; 12(3):279-93. PubMed ID: 25925208
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.
Masui O; White NM; DeSouza LV; Krakovska O; Matta A; Metias S; Khalil B; Romaschin AD; Honey RJ; Stewart R; Pace K; Bjarnason GA; Siu KW; Yousef GM
Mol Cell Proteomics; 2013 Jan; 12(1):132-44. PubMed ID: 23082029
[TBL] [Abstract][Full Text] [Related]
15. Proteomic contributions to personalized cancer care.
Koomen JM; Haura EB; Bepler G; Sutphen R; Remily-Wood ER; Benson K; Hussein M; Hazlehurst LA; Yeatman TJ; Hildreth LT; Sellers TA; Jacobsen PB; Fenstermacher DA; Dalton WS
Mol Cell Proteomics; 2008 Oct; 7(10):1780-94. PubMed ID: 18664563
[TBL] [Abstract][Full Text] [Related]
16. Optomechanical devices for deep plasma cancer proteomics.
Kosaka PM; Calleja M; Tamayo J
Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
[TBL] [Abstract][Full Text] [Related]
17. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
18. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
19. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers.
Moosavi F; Giovannetti E; Saso L; Firuzi O
Crit Rev Clin Lab Sci; 2019 Dec; 56(8):533-566. PubMed ID: 31512514
[TBL] [Abstract][Full Text] [Related]
20. Sieving through the cancer secretome.
Lin Q; Tan HT; Lim HS; Chung MC
Biochim Biophys Acta; 2013 Nov; 1834(11):2360-71. PubMed ID: 23376431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]